If the key issues of miRNA transport vectors and miRNA efficacy in cancer cells can be addressed in the future, mimics or antagonists targeting miRNAs upstream of FBXW7 may slow breast cancer progression. This evidence concerns the gene FBXW7 and breast cancer.